Brief: Uni-Bio Science Group Says GLP-1 RAS Can Treat Wide Range Of High Value Indications Including Covid-19
18/09/2020 11:30
Sept 18 (Reuters) - Uni-Bio Science Group Ltd 0690.HK :
* BASED ON NEW DATA, GLP-1 RAS CAN TREAT WIDE RANGE OF HIGH
VALUE
INDICATIONS INCLUDING COVID-19
Source text for Eikon: urn:newsml:reuters.com:*:nHKS41fDLy
Further company coverage: 0690.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Uni-Bio Science
See all newsBrief: Uni-Bio Science Signs Agreement With WMU NERC And Wenzhou Ouhai District Government
Brief: Uni-Bio Science's Unit Expands Global Reach Of Bogutai Through Strategic Partnership
Brief: Uni-Bio Science Group Says Marketing Application Of Isavuconazonium- Sulfate Capsules Accepted NMPA
Brief: Uni-Bio Science Group Says Marketing Application Of Diquafosol Sodium Eye Drops Officially Approved By NMPA
Brief: Uni-Bio Science Declares Final Dividend Of Hk0.277 Cents Per Share